Cargando…
Plasma-Based Genotyping in Advanced Solid Tumors: A Comprehensive Review
SIMPLE SUMMARY: Targeted therapy is at the forefront of cancer diagnosis and treatment today for multiple advanced tumors. Although molecular testing of tumour tissue biopsies remains the gold standard for molecular diagnosis, it has certain limitations. There have been major advances in the use of...
Autores principales: | Makarem, Maisam, García-Pardo, Miguel, Leighl, Natasha B. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8582457/ https://www.ncbi.nlm.nih.gov/pubmed/34771462 http://dx.doi.org/10.3390/cancers13215299 |
Ejemplares similares
-
Integrating circulating-free DNA (cfDNA) analysis into clinical practice: opportunities and challenges
por: García-Pardo, Miguel, et al.
Publicado: (2022) -
Reflex ROS1 IHC Screening with FISH Confirmation for Advanced Non-Small Cell Lung Cancer—A Cost-Efficient Strategy in a Public Healthcare System
por: Makarem, Maisam, et al.
Publicado: (2021) -
AKT in Bone Metastasis of Solid Tumors: A Comprehensive Review
por: Hinz, Nico, et al.
Publicado: (2021) -
Review of the use of pretest probability for molecular testing in non-small cell lung cancer and overview of new mutations that may affect clinical practice
por: Martin, Petra, et al.
Publicado: (2017) -
Health and Budget Impact of Liquid-Biopsy-Based Comprehensive Genomic Profile (CGP) Testing in Tissue-Limited Advanced Non-Small Cell Lung Cancer (aNSCLC) Patients
por: Patel, Yuti P., et al.
Publicado: (2021)